Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica D Dommasch

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JAMA Dermatology|June 22, 2017
Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013Erica D Dommasch, Cara J Joyce, Arash Mostaghimi
JAMA Dermatology|May 11, 2019
Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of PsoriasisErica D Dommasch, Seoyoung C Kim, Moa P Lee, et al.
Journal of the American Academy of Dermatology|November 10, 2021
Androgenetic alopecia in transgender and gender diverse populations: A review of therapeuticsJulia L Gao, Carl G Streed, Julie Thompson, et al.
Journal of the American Academy of Dermatology|July 8, 2018
Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort studyErica D Dommasch, Moa P Lee, Cara J Joyce, et al.
Journal of the American Academy of Dermatology|February 15, 2011
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trialsErica D Dommasch, Katrina Abuabara, Daniel B Shin, et al.
Journal of the American Academy of Dermatology|February 13, 2023
Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort studyJulia L Gao, Jessika Sanz, Nicholas Tan, et al.
The Journal of Investigative Dermatology|May 22, 2009
The risk of stroke in patients with psoriasisJoel M Gelfand, Erica D Dommasch, Daniel B Shin, et al.
JAMA Dermatology|January 20, 2021
Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone TherapyNick Thoreson, Jason A Park, Chris Grasso, et al.
JAMA Dermatology|May 29, 2024
Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone TherapyJames Choe, Ali Shields, Alana Ferreira, et al.
Journal of the American Academy of Dermatology|January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJoel M Gelfand, April W Armstrong, Stacie Bell, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA Dermatology|June 22, 2017
Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013Erica D Dommasch, Cara J Joyce, Arash Mostaghimi
JAMA Dermatology|May 11, 2019
Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of PsoriasisErica D Dommasch, Seoyoung C Kim, Moa P Lee, et al.
Journal of the American Academy of Dermatology|November 10, 2021
Androgenetic alopecia in transgender and gender diverse populations: A review of therapeuticsJulia L Gao, Carl G Streed, Julie Thompson, et al.
Journal of the American Academy of Dermatology|July 8, 2018
Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort studyErica D Dommasch, Moa P Lee, Cara J Joyce, et al.
Journal of the American Academy of Dermatology|February 15, 2011
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trialsErica D Dommasch, Katrina Abuabara, Daniel B Shin, et al.
Journal of the American Academy of Dermatology|February 13, 2023
Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort studyJulia L Gao, Jessika Sanz, Nicholas Tan, et al.
The Journal of Investigative Dermatology|May 22, 2009
The risk of stroke in patients with psoriasisJoel M Gelfand, Erica D Dommasch, Daniel B Shin, et al.
JAMA Dermatology|January 20, 2021
Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone TherapyNick Thoreson, Jason A Park, Chris Grasso, et al.
JAMA Dermatology|May 29, 2024
Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone TherapyJames Choe, Ali Shields, Alana Ferreira, et al.
Journal of the American Academy of Dermatology|January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJoel M Gelfand, April W Armstrong, Stacie Bell, et al.
Pageof 2